Most Read Articles
01 Jan 2016
The thyroid gland was hypovascular, coarse,  hyperechoic, and had substantially decreased in mean total volume among Graves' hyperthyroidism patients following radioiodine therapy, based on a study
Yesterday
Global hypomethylation of Alu appears to increasingly influence distant metastatic differentiated thyroid cancer (DTC), poorly (P)DTC and anaplastic (A)TC, according to a recent study. This suggests that the epigenetic entity may be involved in thyroid cancer progression and dedifferentiation.
01 Nov 2015
Increased serum prolidase levels in Grave's disease patients without ophthalmopathy signs are positively associated with oxidative stress parameters as shown in a study.
01 Dec 2013
This is a global review of the diagnosis and management of Graves disease.

Incident CVD risk in prolactinoma elevated only in male patients

09 Nov 2017

Men with prolactinoma are at an increased risk of developing cardiovascular disease (CVD), whereas there is no evidence to suggest such an increase in female patients, according to a study.

Researchers drew data from The Health Improvement Network database, identifying 2,233 patients with prolactinoma and 10,355 controls matched according to sex, age, body mass index and smoking status.

The primary outcome was any incident CVD (myocardial infarction, angina pectoris, stroke, transient ischaemic attack or heart failure), the sex-specific adjusted incidence rate ratios (aIRRs) of which were calculated using Poisson regression. Sensitivity analyses were also performed.

The composite CVD outcome occurred in 54 prolactinoma patients and 180 controls during the 6-year observation period, resulting in an incidence rate of 1.8 and 14.8 per 1,000 person-years in females and males, respectively.

Estimated aIRRs for CVD were 0.99 (95 percent CI, 0.61 to 1.61; p=0.968) in female patients and 1.94 (1.29 to 2.91; p=0.001) in male patients. The gender-specific difference in the incidence of CVD was maintained through sensitivity analyses limited to patients with documented record of dopamine agonist treatment and those with newly diagnosed prolactinoma.

Researchers pointed out that the CVD risk in male patients remained elevated even in the presence of concurrent documented treatment with dopamine agonist. Potential mechanisms underlying the association between prolactinoma and CVD might include long-standing hyperprolactinaemia and its consequences, as well as hypopituitarism and its management.

The impact of the present gender-specific finding on the long-term mortality of prolactinoma patients has yet to be elucidated, researchers added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jan 2016
The thyroid gland was hypovascular, coarse,  hyperechoic, and had substantially decreased in mean total volume among Graves' hyperthyroidism patients following radioiodine therapy, based on a study
Yesterday
Global hypomethylation of Alu appears to increasingly influence distant metastatic differentiated thyroid cancer (DTC), poorly (P)DTC and anaplastic (A)TC, according to a recent study. This suggests that the epigenetic entity may be involved in thyroid cancer progression and dedifferentiation.
01 Nov 2015
Increased serum prolidase levels in Grave's disease patients without ophthalmopathy signs are positively associated with oxidative stress parameters as shown in a study.
01 Dec 2013
This is a global review of the diagnosis and management of Graves disease.